vimarsana.com

Page 305 - உலகளாவிய நட்சத்திரம் பயணம் மேலாண்மை News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Epredia And Paige Announce Global Commercial Distribution Agreement For Digital Pathology Software

Epredia And Paige Announce Global Commercial Distribution Agreement For Digital Pathology Software PORTSMOUTH, N.H., March 17, 2021 /PRNewswire/ Epredia, a global leader in precision cancer diagnostics, and Paige, a global leader in AI-based diagnostic software in pathology, have announced today that they have entered into a commercial distribution agreement for Paige s comprehensive portfolio of diagnostic software solutions. Under the terms of this agreement, Epredia has been appointed as a global distribution partner of the entire Paige portfolio of imaging diagnostic solutions. In addition, Epredia will have exclusive distribution rights in Japan. In the second quarter of 2021, Epredia will begin to commercialize the Paige solutions alongside existing Epredia products in the United States and major European Countries, further strengthening its comprehensive digital pathology portfolio that already includes the best-in-class CE-marked 3DHistech P1000 scanner .

Dollar falters as Fed dashes early U S rate hike view

3 Min Read NEW YORK (Reuters) - The U.S. dollar fell on Wednesday, after the Federal Reserve said it does not expect to raise interest rates through all of 2023, contrary to market expectations. FILE PHOTO: U.S. one dollar banknotes are seen in this illustration taken February 8, 2021. REUTERS/Dado Ruvic/Illustration The dollar index dropped 0.5% to 91.405 after the Fed comments. The greenback had reversed its slide in recent sessions on a surge in U.S. Treasury yields due in part to growing expectations that the Fed may tighten rates earlier than thought on forecasts of a faster-than-expected economic recovery. U.S. benchmark 10-year Treasury yields hit a 13-month high early in the session but was last at 1.647%.

U S Treasury yields hit new highs as key Fed statement looms

3 Min Read NEW YORK (Reuters) - A gauge of global stocks gained on Wednesday and the U.S. dollar slid after the Federal Reserve repeated its pledge to keep its target interest rate near zero for years to come. FILE PHOTO: The Wall Street sign is pictured at the New York Stock exchange (NYSE) in the Manhattan borough of New York City, New York, U.S., March 9, 2020. REUTERS/Carlo Allegri The yield on the benchmark U.S. Treasury note, whose surge has roiled markets in recent weeks, fell back after hitting its highest level since January 2020 ahead of the highly anticipated statement from the central bank.

CO2 Science

Paper Reviewed Kim, J.-H., Kim, N., Moon, H., Lee, S., Jeong, S.Y., Diaz-Pulido, G., Edwards, M.S., Kang, J.-H., Kang, E.J., Oh, H.-J., Hwang, J.-D. and Kim, I.-N. 2020. Global warming offsets the ecophysiological stress of ocean acidification on temperate crustose coralline algae. Marine Pollution Bulletin 157: 111324. Crustose coralline algae (CCA) are calcifying seaweeds that inhabit intertidal and subtidal zones all across the ocean. They are ecologically important in that they contribute to primary production and carbonate sand production, facilitate invertebrate larval settlement and provide habitat for numerous marine species. Given such contributions to coastal habitats and systems ecology, Kim

Epredia And Paige Announce Global Commercial Distribution Agreement [ ]

17 marzo 2021 18:54 Fonte: Adnkronos #salute-e-benessere - PORTSMOUTH, N.H., March 17, 2021 /PRNewswire/  Epredia, a global leader in precision cancer diagnostics, and Paige, a global leader in AI-based diagnostic software in pathology, have announced today that they have entered into a commercial distribution agreement for Paige s comprehensive portfolio of diagnostic software solutions.     Under the terms of this agreement, Epredia has been appointed as a global distribution partner of the entire Paige portfolio of imaging diagnostic solutions. In addition, Epredia will have exclusive distribution rights in Japan. In the second quarter of 2021, Epredia will begin to commercialize the Paige solutions alongside existing Epredia products in the United States and major European Countries, further strengthening its comprehensive digital pathology portfolio that already includes the best-in-class CE-marked 3DHistech P1000 scanner .

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.